Kevin Hern | Vice President, Investor Relations |
Dave Ricks | Chairman and CEO |
Josh Smiley | Chief Financial Officer |
Dr. Dan Skovronsky | President, Lilly Research Laboratories |
Christi Shaw | President, Lilly Bio-Medicines |
Anne White | President, Lilly Oncology |
Enrique Conterno | President, Lilly Diabetes and Lilly USA |
Kim Macko | Investor Relations |
Mike Czapar | Investor Relations |
Chris Schott | JPMorgan |
Jason Gerberry | Bank of America |
Seamus Fernandez | Guggenheim |
Tim Anderson | Wolfe |
Geoff Meacham | Barclays |
Andrew Baum | Citi |
Vamil Divan | Credit Suisse |
Umer Raffat | Evercore |
David Risinger | Morgan Stanley |
Steve Scala | Cowen |
Alex Arfaei | BMO |
Louise Chen | Cantor |
Navin Jacob | UBS |
Thank you, ladies and gentlemen, for standing by. Welcome to the Q1 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded.